Molecular markers of phenotype, therapeutic responsiveness and prognosis in human cancers.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/535903

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This proposal aims to identify molecular markers that can be used to classify subtypes of particular cancers according to their prognosis and response to therapy. This will optimise selection of patients for the most appropriate treatment and lead to the development of new therapeutic strategies.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2013

Funding Scheme: Programs

Funding Amount: $11,762,117.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology And Carcinogenesis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Breast Cancer, Prostate Cancer | Cancer and related disorders, Molecular Oncology | Cancer: mechanisms of growth, invasion, metastases | Pancreatic Cancer | Prognostic Markers

Related Links